文献速递关节外科

全国范围内关节置换标本的组织学检查是否一致?一项大型数据库研究

Are Histological Examinations of Arthroplasty Specimens Performed Consistently Across the Country? A Large Database Study.
PubMed 文献 · Clin Orthop Relat Res · 2019-01-01

基于Premier医疗数据库(2006-2016年)的87,667例肩关节、564,577例髋关节和1,131,323例膝关节置换数据,评估常规组织学检查的使用情况。多数医院的使用率呈两极分布(罕见1%-10%或普遍91%-100%),小医院、东北部地区和城市医院使用更多,且使用率随时间缓慢下降(肩34%→30%,全髋50%→45%,全膝43%→38%,均p<0.001)。

要点

  • 多数医院对关节置换标本的组织学检查使用率呈两极分布:罕见(1%-10%)或普遍(91%-100%)。
  • 小医院、东北部地区和城市医院的组织学检查使用率更高(标准化差异>10%)。
  • 2006年至2016年,组织学检查使用率缓慢下降:肩34%→30%,全髋50%→45%,全膝43%→38%(均p<0.001)。

核心结论

  • 尽管总体使用率在下降,但相当数量的医院仍常规对关节置换标本进行组织学检查。
  • 地区和医院类型间的差异提示该实践受多种因素驱动。
  • 这是首项针对全国使用情况的研究,有助于个体医院评估其与国家使用模式的比较。

研究设计与样本

  • 基于Premier医疗数据库(2006-2016年)的回顾性数据库研究,纳入87,667例肩关节置换(595家医院,中位年龄70岁,16%非白人)、564,577例髋关节置换(629家医院,中位年龄65岁,21%非白人)和1,131,323例膝关节置换(630家医院,中位年龄66岁,24%非白人),均为择期手术。
  • 研究医院主要集中在美国南部(约40%),东北部、西部和中西部各约20%。
  • 通过当前操作术语代码评估组织学检查频率,并按医院特征、地理区域和年份分层分析。
  • 采用标准化差异>0.1(或10%)评估组间差异,趋势显著性采用p值。

主要发现

  • 多数医院的组织学检查使用率呈两极分布:肩关节置换中罕见(1%-10%)见于595家中的187家,普遍(91%-100%)见于595家中的121家;髋关节置换中罕见见于629家中的189家,普遍见于629家中的220家;膝关节置换中罕见见于630家中的254家,普遍见于630家中的195家。
  • 小医院的组织学检查使用率高于大医院(37%-53% vs 26%-45%)。
  • 东北部地区的使用率高于其他地区(59%-68% vs 22%-44%)。
  • 城市地区的使用率高于农村地区(32%-49% vs 20%-31%);上述差异的标准化差异均>10%。
  • 2006年至2016年,组织学检查使用率下降:肩关节置换从34%降至30%,全髋关节置换从50%降至45%,全膝关节置换从43%降至38%(均p<0.001)。

关键数值与推荐

  • 组织学检查定义为通过当前操作术语代码识别。
  • 组间差异采用标准化差异>0.1(或10%)视为有意义差异。
  • 趋势显著性采用p值,报告为p<0.001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is currently unknown to what extent routine histological examination of joint arthroplasty specimens occurs across hospitals nationwide. Although this practice is neither supported nor refuted by the available evidence, given the increasing demand for joint arthroplasties, it is crucial to study overall utilization as well as its main drivers. QUESTIONS/PURPOSES: Using national data on joint replacements, we aimed to evaluate: (1) What is the current use of routine histological examination of joint arthroplasty specimens? (2) Does the use vary by geographic location and hospital characteristics? (3) Has use changed over time? METHODS: From the Premier Healthcare database (2006-2016) we included claims data from 87,667 shoulder (595 hospitals, median age 70 years, 16% nonwhite), 564,577 hip (629 hospitals, median age 65 years, 21% nonwhite), and 1,131,323 (630 hospitals, median age 66 years, 24% nonwhite) knee arthroplasties (all elective). Our study group has extensive experience with this data set, which contains information on 20% to 25% of all US hospitalizations. Included hospitals are mainly concentrated in the South (approximately 40%) with equal distributions among the Northeast, West, and Midwest (approximately 20% each). Moreover, the Premier data set has detailed billing information, which allows for evaluations of real-world clinical practice. There was no missing information on the main variables of interest for this specific study. We assessed frequency of histology examination (defined by Current Procedural Terminology codes) overall as well as by hospital characteristics (urban/rural, bed size, teaching status, arthroplasty volume), geographic region (Northeast, South, Midwest, West), and year. Given the large sample size, instead of p values, standardized differences were applied in assessing group differences where a standardized difference of > 0.1 (or 10%) was assumed to represent a meaningful difference between groups. For significance of trends, p values were applied. Percentages provided represent proportions of individual procedures. RESULTS: In most hospitals, histology testing was either rare (1%-10%, used in 187 of 595, 189 of 629, and 254 of 630 hospitals) or ubiquitous (91%-100%, used in 121 of 595, 220 of 629, and 195 of 630 hospitals) for shoulder, hip, and knee arthroplasties, respectively. Overall, histology testing occurred more often in smaller hospitals (37%-53% compared with 26%-45% in larger hospitals) and those located in the Northeast (59%-68% compared with 22%-44% in other regions) and urban areas (32%-49% compared with 20%-31% in rural areas), all with standardized differences > 10%. Histologic examination is slowly decreasing over time: from 2006 to 2016, it decreased from 34% to 30% for shoulder arthroplasty, from 50% to 45% for THAs, and from 43% to 38% for TKAs (all p < 0.001). CONCLUSIONS: Although overall use is decreasing, a substantial number of hospitals still routinely perform histology testing of arthroplasty specimens. Moreover, variation between regions and hospital types suggests that this practice is driven by a variety of factors. This is the first study addressing national utilization, which will be helpful for individual hospitals to assess how they compare with national utilization patterns. Moreover, the findings have clear implications for followup studies, which may be necessary given the exponentially growing demand for arthroplasties. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Suchman KI, Poeran J, Huang HH, et al. Are Histological Examinations of Arthroplasty Specimens Performed Consistently Across the Country? A Large Database Study. Clin Orthop Relat Res. 2019. PMID: 30801277. doi:10.1097/CORR.0000000000000635

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。